Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii

Nature Reviews Microbiology

Volumn 11, Issue 8, 2013, Pages 561-573

  Van Schaik, Erin J ^a   Chen, Chen ^a   Mertens, Katja ^a,b   Weber, Mary M ^a   Samuel, James E ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; TETRACYCLINE;

BACTERIAL GENOME; BACTERIAL VIRULENCE; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CLINICAL FEATURE; COXIELLA BURNETII; DISEASE DURATION; DISEASE TRANSMISSION; HEADACHE; HEPATITIS; IMMUNE EVASION; INTRACELLULAR BACTERIUM; MALAISE; MOLECULAR PATHOLOGY; MYALGIA; NONHUMAN; PHAGOSOME; PNEUMONIA; PRIORITY JOURNAL; Q FEVER; REVIEW; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPECIES INVASION;

ANIMALS; APOPTOSIS; BACTERIAL ADHESION; COXIELLA BURNETII; HOST-PATHOGEN INTERACTIONS; HUMANS; INTEGRIN ALPHAVBETA3; INTRACELLULAR MEMBRANES; PHAGOCYTOSIS; PHAGOSOMES; Q FEVER; TIME FACTORS; VACUOLES;

BACTERIA (MICROORGANISMS); COXIELLA; COXIELLA BURNETII;

EID: 84880506847     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3049     Document Type: Review

References (132)

1. Flannagan, R. S., Jaumouill, V. & Grinstein, S. The cell biology of phagocytosis. Annu. Rev. Pathol. 7, 61-98 (2012
2. Flannagan, R. S., Cosio, G. & Grinstein, S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nature Rev. Microbiol. 7, 355-366 (2009
3. Beron, W., Gutierrez, M. G., Rabinovitch, M. & Colombo, M. I. Coxiella burnetii localizes in a Rab7 labeled compartment with autophagic characteristics. Infect. Immun. 70, 5816-5821 (2002
4. Howe, D. & Mallavia, L. P. Coxiella burnetii exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells. Infect. Immun. 68, 3815-3821 (2000
5. Howe, D., Melnicâakova, J., Barâak, I. & Heinzen, R. A. Fusogenicity of the Coxiella burnetii parasitophorous vacuole. Ann. NY Acad. Sci. 990, 556-562 (2003
6. Coleman, S. A., Fischer, E. R., Howe, D., Mead, D. J. & Heinzen, R. A. Temporal analysis of Coxiella burnetii morphological differentiation. J. Bacteriol. 186, 7344-7352 (2004
7. Coleman, S. A. et al. Proteome and antigen profiling of Coxiella burnetii developmental forms. Infect. Immun. 75, 290-298 (2007
8. Stoker, M. B. P. & Fiset, P. Phase variation of the Nine Mile and other strains of Rickettsia burnetii. Can. J. Microbiol. 2, 310-321 (1956
9. Baca, O. G., Klassen, D. A. & Aragon, A. S. Entry of Coxiella burnetii into host cells. Acta Virol. 37, 143-155 (1993
10. Tujulin, E., Macellaro, A., Lilliehook, B. & Norlander, L. Effect of endocytosis inhibitors on Coxiella burnetii interaction with host cells. Acta Virol. 42, 125-131 (1998
11. Seshadri, R. et al. Complete genome sequence of the Q fever pathogen Coxiella burnetii. Proc. Natl Acad. Sci. USA 100, 5455-5460 (2003
12. Beare, P. A. et al. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. mBio 2, e00175 11 (2011
13. Carey, K. L., Newton, H. J., Luhrmann, A. & Roy, C. R. The Coxiella burnetii Dot/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication. PLoS Pathog. 7, e1002056 (2011
14. Capo, C. et al. Subversion of monocyte functions by Coxiella burnetii: Impairment of the cross-talk between avß3 integrin and CR3. J. Immunol. 163, 6078-6085 (1999
15. Dellacasagrande, J. et al. avß3 integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes. Infect. Immun. 68, 5673-5678 (2000
16. Dupuy, A. G. & Caron, E. Integrin-dependent phagocytosis - spreading from microadhesion to new concepts. J. Cell Sci. 121, 1773-1783 (2008
17. De Fougerolles, A. R. & Koteliansky, V. E. Regulation of monocyte gene expression by the extracellular matrix and its functional implications. Immunol. Rev. 186, 208-220 (2002
18. Damjanovich, L., Albelda, S. M., Mette, S. A. & Buck, C. A. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am. J. Respir. Cell Mol. Biol. 6, 197-206 (1992
19. Russell-Lodrigue, K. E., Zhang, G. Q., McMurray, D. N. & Samuel, J. E. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect. Immun. 74, 6085-6091 (2006
20. Moos, A. & Hackstadt, T. Comparative virulence of intra-and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect. Immun. 55, 1144-1150 (1987
21. Howe, D., Shannon, J. G., Winfree, S., Dorward, D. W. & Heinzen, R. A. Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages. Infect. Immun. 78, 3465-3474 (2010
22. Romano, P. S., Gutierrez, M. G., Beron, W., Rabinovitch, M. & Colombo, M. I. The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell. Cell. Microbiol. 9, 891-909 (2007
23. Fu, Y. & Galan, J. E. A Salmonella protein antagonizes Rac 1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401, 293-297 (1999
24. Subtil, A., Wyplosz, B., Balana, M. E. & Dautry-Varsat, A. Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity. J. Cell Sci. 117, 3923-3933 (2004
25. Meconi, S. et al. Activation of protein tyrosine kinases by Coxiella burnetii: Role in actin cytoskeleton reorganization and bacterial phagocytosis. Infect. Immun. 69, 2520-2526 (2001
26. Meconi, S. et al. Coxiella burnetii induces reorganization of the actin cytoskeleton in human monocytes. Infect. Immun. 66, 5527-5533 (1998
27. Honstettre, A. et al. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J. Immunol. 172, 3695-3703 (2004
28. Kinchen, J. M. & Ravichandran, K. S. Phagosome maturation: Going through the acid test. Nature Rev. Mol. Cell Biol. 9, 781-795 (2008
29. Voth, D. E. & Heinzen, R. A. Lounging in a lysosome: The intracellular lifestyle of Coxiella burnetii. Cell. Microbiol. 9, 829-840 (2007
30. Howe, D., Melnicâakovâa, J., Barâak, I. & Heinzen, R. A. Maturation of the Coxiella burnetii parasitophorous vacuole requires bacterial protein synthesis but not replication. Cell. Microbiol. 5, 469-480 (2003
31. Levine, B., Mizushima, N. & Virgin, H. W. Autophagy in immunity and inflammation. Nature 469, 323-335 (2011
32. Gutierrez, M. G. et al. Autophagy induction favours the generation and maturation of the Coxiella-replicative vacuoles. Cell. Microbiol. 7, 981-993 (2005
33. McDonough, J. A. et al. Host pathways important for Coxiella burnetii infection revealed by genome-wide RNA interference screening. mBio 4, e00606 12 (2013
34. Roman, M. J., Crissman, H. A., Samsonoff, W. A., Hechemy, K. E. & Baca, O. G. Analysis of Coxiella burnetii isolates in cell culture and the expression of parasite-specific antigens on the host membrane surface. Acta Virol. 35, 503-510 (1991
35. Aguilera, M. et al. Actin dynamics and Rho GTPases regulate the size and formation of parasitophorous vacuoles containing Coxiella burnetii. Infect. Immun. 77, 4609-4620 (2009
36. Hussain, S. K., Broederdorf, L. J., Sharma, U. M. & Voth, D. E. Host kinase activity is required for Coxiella burnetii parasitophorous vacuole formation. Front. Microbiol. 1, 137 (2010
37. Campoy, E. M., Zoppino, F. C. & Colombo, M. I. The early secretory pathway contributes to the growth of the Coxiella-replicative niche. Infect. Immun. 79, 402-413 (2011
38. Howe, D. & Heinzen, R. A. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell. Microbiol. 8, 496-507 (2006
39. Howe, D. & Heinzen, R. A. Replication of Coxiella burnetii is inhibited in CHO K-1 cells treated with inhibitors of cholesterol metabolism. Ann. NY Acad. Sci. 1063, 123-129 (2005
40. Espenshade, P. J. & Hughes, A. L. Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41, 401-427 (2007
41. Akporiaye, E. T., Rowatt, J. D., Aragon, A. A. & Baca,O. G. Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii. Infect. Immun. 40, 1155-1162 (1983
42. Voth, D. E., Howe, D. & Heinzen, R. A. Coxiella burnetii inhibits apoptosis in human THP 1 cells and monkey primary alveolar macrophages. Infect. Immun. 75, 4263-4271 (2007
43. Baca, O. G., Scott, T. O., Akporiaye, E. T., DeBlassie, R. & Crissman, H. A. Cell cycle distribution patterns and generation times of L929 fibroblast cells persistently infected with Coxiella burnetii. Infect. Immun. 47, 366-369 (1985
44. Luhrmann, A. & Roy, C. R. Coxiella burnetii inhibits activation of host cell apoptosis through a mechanism that involves preventing cytochrome c release from mitochondria. Infect. Immun. 75, 5282-5289 (2007
45. Yang, J. et al. Prevention of apoptosis by Bcl 2: Release of cytochrome c from mitochondria blocked. Science 275, 1129-1132 (1997
46. Voth, D. E. & Heinzen, R. A. Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity. Infect. Immun. 77, 205-213 (2009
47. Roman, M. J., Coriz, P. D. & Baca, O. G. A proposed model to explain persistent infection of host cells with Coxiella burnetii. J. Gen. Microbiol. 132, 1415-1422 (1986
48. Tigertt, W. D., Benenson, A. S. & Gochenour, W. S. Airborne Q fever. Bacteriol. Rev. 25, 285-293 (1961
49. Zhang, Y., Zhang, G., Hendrix, L. R., Tesh, V. L. & Samuel, J. E. Coxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP 1 cells. PLoS ONE 7, e30841 (2012
50. Ashida, H. et al. Cell death and infection: A double-edged sword for host and pathogen survival. J. Cell Biol. 195, 931-942 (2011
51. Beare, P. A. et al. Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect. Immun. 77, 642-656 (2009
52. Peabody, C. R. et al. Type II protein secretion and its relationship to bacterial type IV pili and archaeal flagella. Microbiology 149, 3051-3072 (2003
53. Sexton, J. A. & Vogel, J. P. Type IVB secretion by intracellular pathogens. Traffic 3, 178-185 (2002
54. Zechner, E. L., Lang, S. & Schildbach, J. F. Assembly and mechanisms of bacterial type IV secretion machines. Phil. Trans. R. Soc. B. 367, 1073-1087 (2012
55. Alvarez-Martinez, C. E. & Christie, P. J. Biological diversity of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73, 775-808 (2009
56. Vincent, C. D. et al. Identification of the core transmembrane complex of the Legionella Dot/Icm type IV secretion system. Mol. Microbiol. 62, 1278-1291 (2006
57. Vincent, C. D., Friedman, J. R., Jeong, K. C., Sutherland, M. C. & Vogel, J. P. Identification of the DotL coupling protein subcomplex of the Legionella Dot/Icm type IV secretion system. Mol. Microbiol. 85, 378-391 (2012
58. Hiroki, N. & Tomoko, K. Type IVB secretion systems of Legionella and other Gram-negative bacteria. Front. Microbiol. 2, 136 (2011
59. Zamboni, D. S., McGrath, S., Rabinovitch, M. & Roy, C. R. Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophila Dot/Icm system. Mol. Microbiol. 49, 965-976 (2003
60. Voth, D. E. et al. The Coxiella burnetii ankyrin repeat domain-containing protein family is heterogeneous with C terminal truncations that influence Dot/Icm-mediated secretion. J. Bacteriol. 191, 4232-4242 (2009
61. Chen, C. et al. Large-scale identification and translocation of type IV secretion substrates by Coxiella burnetii. Proc. Natl Acad. Sci. USA 107, 21755-21760 (2010
62. Morgan, J. K., Luedtke, B. E., Thompson, H. A. & Shaw, E. I. Coxiella burnetii type IVB secretion system region I genes are expressed early during the infection of host cells. FEMS Microbiol. Lett. 311, 61-69 (2010
63. Morgan, J. K., Luedtke, B. E. & Shaw, E. I. Polar localization of the Coxiella burnetii type IVB secretion system. FEMS Microbiol. Lett. 305, 177-183 (2010
64. Beare, P. A., Larson, C. L., Gilk, S. D. & Heinzen, R. A. Two systems for targeted gene deletion in Coxiella burnetii. Appl. Environ. Microbiol. 78, 4580-4589 (2012
65. Pan, X., Luhrmann, A., Satoh, A., Laskowski-Arce, M. A. & Roy, C. R. Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors. Science 320, 1651-1654 (2008
66. Voth, D. E. & Heinzen, R. A. Coxiella type IV secretion and cellular microbiology. Curr. Opin. Microbiol. 12, 74-80 (2009
67. Voth, D. E. et al. The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates. J. Bacteriol. 193, 1493-1503 (2011
68. Lifshitz, Z. et al. Computational modeling and experimental validation of the Legionella and Coxiella virulence-related type-IVB secretion signal. Proc. Natl Acad. Sci. USA 110, e707-e715 (2013
69. de Felipe, K. S. et al. Evidence for acquisition of Legionella type IV secretion substrates via interdomain horizontal gene transfer. J. Bacteriol. 187, 7716-7726 (2005
70. Kubori, T., Shinzawa, N., Kanuka, H. & Nagai, H. Legionella metaeffector exploits host proteasome to temporally regulate cognate effector. PLoS Pathog. 6, e1001216 (2011
71. Newton, H. J., McDonough, J. A. & Roy, C. R. Effector protein translocation by the Coxiella burnetii Dot/Icm type IV secretion system requires endocytic maturation of the pathogen-occupied vacuole. PLoS ONE 8, e54566 (2013
72. Zusman, T. et al. The response regulator PmrA is a major regulator of the icm/dot type IV secretion system in Legionella pneumophila and Coxiella burnetii. Mol. Microbiol. 63, 1508-1523 (2007
73. McPhee, J. B., Lewenza, S. & Hancock, R. E. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50, 205-217 (2003
74. Sauer, J. D. et al. Specificity of Legionella pneumophila and Coxiella burnetii vacuoles and versatility of Legionella pneumophila revealed by coinfection. Infect. Immun. 73, 4494-4504 (2005
75. Omsland, A. et al. Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium. Appl. Environ. Microbiol. 77, 3720-3725 (2011
76. Huang, L. et al. The E Block motif is associated with Legionella pneumophila translocated substrates. Cell. Microbiol. 13, 227-245 (2011
77. Klingenbeck, L., Eckart, R. A., Berens, C. & Luhrmann, A. The Coxiella burnetii type IV secretion system substrate CaeB inhibits intrinsic apoptosis at the mitochondrial level. Cell. Microbiol. 15, 675-687 (2013
78. Luhrmann, A., Nogueira, C. V., Carey, K. L. & Roy, C. R. Inhibition of pathogen-induced apoptosis by a Coxiella burnetii type IV effector protein. Proc. Natl Acad. Sci. USA 107, 18997-19001 (2010
79. Ge, J. et al. A Legionella type IV effector activates the NF ?B pathway by phosphorylating the I?B family of inhibitors. Proc. Natl Acad. Sci. USA 106, 13725-13730 (2009
80. de Felipe, K. S. et al. Legionella eukaryotic-like type IV substrates interfere with organelle trafficking. PLoS Pathog. 4, e1000117 (2008
81. Shen, X. et al. Targeting eEF1A by a Legionella pneumophila effector leads to inhibition of protein synthesis and induction of host stress response. Cell. Microbiol. 11, 911-926 (2009
82. Banga, S. et al. Legionella pneumophila inhibits macrophage apoptosis by targeting pro-death members of the Bcl2 protein family. Proc. Natl Acad. Sci. USA 104, 5121-5126 (2007
83. Campodonico, E. M., Chesnel, L. & Roy, C. R. A yeast genetic system for the identification and characterization of substrate proteins transferred into host cells by the Legionella pneumophila Dot/Icm system. Mol. Microbiol. 56, 918-933 (2005
84. Ren, Q., Robertson, S. J., Howe, D., Barrows, L. F. & Heinzen, R. A. Comparative DNA microarray analysis of host cell transcriptional responses to infection by Coxiella burnetii or Chlamydia trachomatis. Ann. NY Acad. Sci. 990, 701-713 (2003
85. Murata, T. et al. The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor. Nature Cell Biol. 8, 971-977 (2006
86. Machner, M. P. & Isberg, R. R. Targeting of host Rab GTPase function by the intravacuolar pathogen Legionella pneumophila. Dev. Cell 11, 47-56 (2006
87. Nagai, H., Kagan, J. C., Zhu, X., Kahn, R. A. & Roy, C. R. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 295, 679-682 (2002
88. Price, C. T., Al Quadan, T., Santic, M., Rosenshine, I. & Abu Kwaik, Y. Host proteasomal degradation generates amino acids essential for intracellular bacterial growth. Science 334, 1553-1557 (2011
89. Vishwanath, S. & Hackstadt, T. Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii. Infect. Immun. 56, 40-44 (1988
90. Shannon, J. G., Howe, D. & Heinzen, R. A. Virulent Coxiella burnetii does not activate human dendritic cells: Role of lipopolysaccharide as a shielding molecule. Proc. Natl Acad. Sci. USA 102, 8722-8727 (2005
91. Zamboni, D. S. et al. Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection. J. Biol. Chem. 279, 54405-54415 (2004
92. Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N. & Weis, J. J. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165, 618-622 (2000
93. Amano, K., Williams, J. C., Missler, S. R. & Reinhold, V. N. Structure and biological relationships of Coxiella burnetii lipopolysaccharide. J. Biol. Chem. 262, 4740-4747 (1987
94. Stoenner, H. G. & Lackman, D. B. The biologic properties of Coxiella burnetii isolated from rodents collected in Utah. Am. J. Hyg. 71, 45-51 (1960
95. Toman, R. et al. Physicochemical characterization of the endotoxins from Coxiella burnetii strain Priscilla in relation to their bioactivities. BMC Biochem. 5, 1 (2004
96. Telepnev, M. V. et al. Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells. J. Infect. Dis. 200, 1694-1702 (2009
97. Benoit, M., Barbarat, B., Bernard, A., Olive, D. & Mege, J. L. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur. J. Immunol. 38, 1065-1070 (2008
98. Dellacasagrande, J., Capo, C., Raoult, D. & Mege, J. L. IFN-?-mediated control of Coxiella burnetii survival in monocytes: The role of cell apoptosis and TNF. J. Immunol. 162, 2259-2265 (1999
99. Howe, D., Barrows, L. F., Lindstrom, N. M. & Heinzen, R. A. Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect. Immun. 70, 5140-5147 (2002
100. Turco, J., Thompson, H. A. & Winkler, H. Interferon ? inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect. Immun. 45, 781-783 (1984
101. Zamboni, D. S. & Rabinovitch, M. Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infect. Immun. 71, 1225-1233 (2003
102. Brennan, R. E., Russell, K., Zhang, G. & Samuel, J. E. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect. Immun. 72, 6666-6675 (2004
103. Hill, J. & Samuel, J. E. Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes. Infect. Immun. 79, 414-420 (2011
104. Siemsen, D. W., Kirpotina, L. N., Jutila, M. A. & Quinn,M. T. Inhibition of the human neutrophil NADPH oxidase by Coxiella burnetii. Microbes Infect. 11, 671-679 (2009
105. Vila-del Sol, V., Diaz-Munoz, M. D. & Fresno, M. Requirement of tumor necrosis factor a and nuclear factor-?B in the induction by IFN-? of inducible nitric oxide synthase in macrophages. J. Leukoc. Biol. 81, 272-283 (2007
106. Vazquez, C. L. & Colombo, M. I. Coxiella burnetii modulates Beclin 1 and Bcl 2, preventing host cell apoptosis to generate a persistent bacterial infection. Cell Death Differ. 17, 421-438 (2010
107. Babudieri, C. Q fever: A zoonosis. Adv. Vet. Sci. 5, 81-84 (1959
108. CDC & Department of Health and Human Services. Possession, use, and transfer of select agents and toxins. Final rule. Fed. Regist. 73, 61363-61366 (2008
109. Fournier, P. E., Marrie, T. J. & Raoult, D. Diagnosis of Q fever. J. Clin. Microbiol. 36, 1823-1834 (1998
110. Million, M., Thuny, F., Richet, H. & Raoult, D. Long-term outcome of Q fever endocarditis: A 26 year personal survey. Lancet Infect. Dis. 10, 527-535 (2010
111. Raoult, D. et al. Treatment of Q fever endocarditis: Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Intern. Med. 159, 167-173 (1999
112. Marmion, B. P. et al. Long-term persistence of Coxiella burnetii after acute primary Q fever. QJM 98, 7-20 (2005
113. Penttila, I. A. et al. Cytokine dysregulation in the post Q fever fatigue syndrome. QJM 91, 549-560 (1998
114. Marmion, B. P., Shannon, M., Maddocks, I., Storm, P. & Penttila, I. Protracted debility and fatigue after acute Q fever. Lancet 347, 977-978 (1996
115. Enserink, M. Infectious diseases. Questions abound in Q fever explosion in the Netherlands. Science 327, 266-267 (2010
116. Whelan, J. et al. Q fever among culling workers, the Netherlands, 2009-2010. Emerg. Infect. Dis. 17, 1719-1723 (2011
117. Roest, H. I. et al. The Q fever epidemic in The Netherlands: History, onset, response and reflection. Epidemiol. Infect. 139, 1-12 (2011
118. Glazunova, O. et al. Coxiella burnetii genotyping. Emerg. Infect. Dis. 11, 1211-1217 (2005
119. Hendrix, L. R., Samuel, J. E. & Mallavia, L. P. Differentiation of Coxiella burnetii isolates by analysis of restriction-endonuclease-digested DNA separated by SDS-PAGE. J. Gen. Microbiol. 137, 269-276 (1991
120. Samuel, J. E., Frazier, M. E. & Mallavia, L. P. Correlation of plasmid type and disease caused by Coxiella burnetii. Infect. Immun. 49, 775-779 (1985
121. Svraka, S., Toman, R., Skultety, L., Slaba, K. & Homan, W. L. Establishment of a genotyping scheme for Coxiella burnetii. FEMS Microbiol. Lett. 254, 268-274 (2006
122. Thiele, D. & Willems, H. Is plasmid based differentiation of Coxiella burnetii in 'acute' and 'chronic' isolates still valid? Eur. J. Epidemiol. 10, 427-434 (1994
123. Beare, P. A. et al. Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons. J. Bacteriol. 188, 2309-2324 (2006
124. Russell-Lodrigue, K. E. et al. Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever. Infect. Immun. 77, 5640-5650 (2009
125. Capo, C. et al. Production of interleukin 10 and transforming growth factor ß by peripheral blood mononuclear cells in Q fever endocarditis. Infect. Immun. 64, 4143-4147 (1996
126. Meghari, S. et al. Persistent Coxiella burnetii infection in mice overexpressing IL 10: An efficient model for chronic Q fever pathogenesis. PLoS Pathog. 4, e23 (2008
127. Chen, S. Y., Hoover, T. A., Thompson, H. A. & Williams, J. C. Characterization of the origin of DNA replication of the Coxiella burnetii chromosome. Ann. NY Acad. Sci. 590, 491-503 (1990
128. Suhan, M. et al. Cloning and characterization of an autonomous replication sequence from Coxiella burnetii. J. Bacteriol. 176, 5233-5243 (1994
129. Hackstadt, T. & Williams, J. C. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc. Natl Acad. Sci. USA 78, 3240-3244 (1981
130. Omsland, A. et al. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc. Natl Acad. Sci. USA 106, 4430-4434 (2009
131. Beare, P. A. et al. Characterization of a Coxiella burnetii ftsZ mutant generated by Himar1 transposon mutagenesis. J. Bacteriol. 191, 1369-1381 (2009
132. Beare, P., Sandoz, K., Omsland, A., Rockey, D. & Heinzen, R. Advances in genetic manipulation of obligate intracellular bacterial pathogens. Front. Microbiol. 2, 97 (2011